Publication:
BEHOLD-2: A phase I/II randomised study evaluating GSK5733584, a B7-H4-targeted antibody-drug conjugate, in combination with anti-cancer agents in patients with advanced solid tumours

Simple item page
dc.contributor.coauthorYamamoto, N.
dc.contributor.coauthorKitano, S.
dc.contributor.coauthorAriyoshi, K.
dc.contributor.coauthorLheureux, S.
dc.contributor.coauthorZeng, X.
dc.contributor.coauthorCinat, G.
dc.contributor.coauthorKowalyszyn, R. D.
dc.contributor.coauthorBares, J. P.
dc.contributor.coauthorFernandez, O. C.
dc.contributor.coauthorVeliz, I. F.
dc.contributor.coauthorUrun, Y.
dc.contributor.coauthorBurns, O.
dc.contributor.coauthorCunningham, L. J.
dc.contributor.coauthorHolden, J.
dc.contributor.coauthorShah, S. D.
dc.contributor.coauthorCrowley, C.
dc.contributor.coauthorFelicetti, B.
dc.contributor.coauthorMalinowska, I.
dc.contributor.coauthorProvencher, D. M.
dc.contributor.departmentKUH (Koç University Hospital)
dc.contributor.kuauthorSelçukbiricik, Fatih
dc.contributor.schoolcollegeinstituteKUH (KOÇ UNIVERSITY HOSPITAL)
dc.date.accessioned2026-08-14T11:20:29Z
dc.date.issued2025
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.versionPublished Version
dc.identifier.ScopusPercentile98
dc.identifier.ScopusQuartileQ1
dc.identifier.WoSPercentile99,2
dc.identifier.WoSQuartileQ1
dc.identifier.doi10.1016/j.annonc.2025.10.1101
dc.identifier.eissn1569-8041
dc.identifier.embargoN/A
dc.identifier.issn0923-7534
dc.identifier.urihttp://doi.org/10.1016/j.annonc.2025.10.1101
dc.identifier.urihttps://hdl.handle.net/20.500.14288/34317
dc.identifier.volume36
dc.identifier.wos001656668100009
dc.keywordsPhases of clinical research
dc.keywordsPhase (matter)
dc.keywordsClinical trial
dc.keywordsChemotherapy
dc.keywordsResponse evaluation criteria in solid tumors
dc.keywordsCancer
dc.languageeng
dc.publisherElsevier
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofAnnals of Oncology
dc.relation.openaccessN/A
dc.rightsN/A
dc.rights.uriN/A
dc.subjectHealth sciences
dc.subjectMedicine
dc.subjectOncology
dc.titleBEHOLD-2: A phase I/II randomised study evaluating GSK5733584, a B7-H4-targeted antibody-drug conjugate, in combination with anti-cancer agents in patients with advanced solid tumours
dc.typeMeeting Abstract
dspace.entity.typePublication
relation.isOrgUnitOfPublicationf91d21f0-6b13-46ce-939a-db68e4c8d2ab
relation.isOrgUnitOfPublication.latestForDiscoveryf91d21f0-6b13-46ce-939a-db68e4c8d2ab
relation.isParentOrgUnitOfPublication055775c9-9efe-43ec-814f-f6d771fa6dee
relation.isParentOrgUnitOfPublication.latestForDiscovery055775c9-9efe-43ec-814f-f6d771fa6dee

Files

Collections

Publications without Fulltext